KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Emergent BioSolutions (EBS) Non-cash Items (2016 - 2017)

Historic Non-cash Items for Emergent BioSolutions (EBS) over the last 7 years, with Q3 2017 value amounting to $38.0 million.

  • Emergent BioSolutions' Non-cash Items changed N/A to $38.0 million in Q3 2017 from the same period last year, while for Sep 2017 it was $38.0 million, marking a year-over-year change of. This contributed to the annual value of $20.0 million for FY2015, which is 3146.35% down from last year.
  • Emergent BioSolutions' Non-cash Items amounted to $38.0 million in Q3 2017.
  • In the past 5 years, Emergent BioSolutions' Non-cash Items ranged from a high of $38.0 million in Q1 2016 and a low of $1.5 million during Q2 2016
  • Over the past 5 years, Emergent BioSolutions' median Non-cash Items value was $3.0 million (recorded in 2013), while the average stood at $14.6 million.
  • As far as peak fluctuations go, Emergent BioSolutions' Non-cash Items surged by 93044.75% in 2014, and later tumbled by 3146.35% in 2015.
  • Quarter analysis of 5 years shows Emergent BioSolutions' Non-cash Items stood at $23.1 million in 2013, then grew by 26.06% to $29.2 million in 2014, then tumbled by 31.46% to $20.0 million in 2015, then crashed by 92.6% to $1.5 million in 2016, then surged by 2467.83% to $38.0 million in 2017.
  • Its Non-cash Items stands at $38.0 million for Q3 2017, versus $1.5 million for Q2 2016 and $38.0 million for Q1 2016.